Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Jarrod W. Pakosh who wrote (673)	10/28/1999 11:09:00 PM
From: Jim Oravetz	Read Replies (3) \| Respond to of 783

As an investment advisor, you should know that the long term view is definitely the preferred why to look at stocks (at least for me!). Some people have better "gut" feelings or luck and can profit from short term price movements. I for one, buy and hold. BCHE was supposed to start raking in the $ from the new drug the last Qtr. Instead, only $800K or so was generated. Some analysts had the numbers as high as $10M. Well, to save face they slammed the stock and its been floating around since than. This Q, the numbers came in at >$10M. Great! Mnge stated after last Q that they would have revenue of $70M this year from the Hep-B drug. Looks like the numbers are picking up. Here are some cut/paste items from one of your posts. Message 1063009 Friday, July 23, 1999 "Investors are realizing that, while they really haven't been paying attention, there has been a lot of value(in biotech's) that has been built up and often is still unrecognized in many of these companies," said Ezra Lwowski, an analyst at Yorkton Securities Inc. in Toronto..... After the gains of the past seven weeks, there is still value in the market, said Ann Dulhanty, an analyst at Dundee Securities Corp. Ms. Dulhanty's current favourites are Biochem Pharma Inc. (BCH/TSE) and Synsorb Biotech Inc. (SYB/TSE) as well as StressGen Biotechnologies Corp. (SSB/TSE). "They come into my category of fundamentally strong companies, and they haven't appreciated as much as some in this current rally," she says.... Patiently waiting. Jim